The properties of an oxyfluoride glass ceramic that possesses high transparency after ceramming are described. Approximately 25 vol % of this material is comprised of cubic, fluoride nanocrystals and the remainder is a predominantly oxide glass. When doped with Pr+3, the fluorescence lifetime at 1300 nm is longer than in a fluorozirconate glass, suggesting that a significant fraction of the rare-earth dopant is preferentially partitioned into the fluoride crystal phase. This material has the added advantage of being compatible with ambient air processing.
The quantum efficiency of the 1.3 μm transition in Pr3+ doped oxyfluoride transparent glass ceramics is measured using a self-calibrating fluorescence ratio technique. The measured value of 8%±1% is much higher than expected for Pr3+ in an oxide glass, and is consistent with the incorporation of the Pr3+ ions into the fluoride nanocrystals of the glass ceramic. Measured quantum efficiencies are compared with values calculated using the Judd–Ofelt theory, and it is found that the best agreement is obtained when fractional differences between calculated and measured oscillator strengths are minimized, rather than absolute differences. The Judd–Ofelt analysis is used along with a spectral analysis to show that excited-state absorption should not significantly reduce the gain around 1.3 μm in these materials. The fluorescence ratio technique used to measure the quantum efficiency also provides information about ion–ion interactions at higher concentrations. It is found that the addition of the monovalent dopant Ag+ reduces the tendency of the Pr3+ ions to cluster, allowing higher concentrations of Pr3+ without significant concentration quenching.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.